Dialysis Market size to exceed $153 Bn by 2032

Dialysis Market size is estimated to be worth over USD 153 billion by the end of 2032, according to a new research report by Global Market Insights Inc.
 

The emergence of diabetes as the leading cause of end-stage renal disease in most developed countries is fueling industry trends. Moreover, the burden of end-stage renal failure caused by diabetes is anticipated to increase in developing countries. Studies indicate that in high-risk populations, over 40% of individuals with T2 DM develop chronic kidney disease (CKD).
 

Moreover, due to metabolic variables and rapid vascular calcification, diabetic dialysis patients suffer higher rates of cardiovascular events and mortality, which is estimated to raise the demand for advanced dialysis products and treatments through 2032.
 

Lifestyle flexibility benefits to complement peritoneal dialysis segment growth

By type, the dialysis market by the peritoneal dialysis segment surpassed USD 12 billion in revenue in 2022 and is expected to grow exponentially through 2032 attributed to the several benefits associated with peritoneal dialysis, including less restricted diet, long-lasting residual kidney function, and lifestyle flexibility. Furthermore, latest advancements in peritoneal dialysis solutions are likely to promote segment expansion.
 

Rising adoption of dialysis machines and water treatment systems to favor the equipment segment

 Equipment segment is anticipated to witness over 4% CAGR through 2032, the report claims. The escalating usage of dialysis equipment, such as dialysis machines and water treatment systems, is expected to drive segment value. Furthermore, increasing product need to minimize the rising incidences of fluid overload in newborns and children along with ongoing R&D efforts by industry participants to provide new dialysis equipment are expected to drive segment progression through 2032.
 

Availability of innovative technology to promote the in-center dialysis segment expansion

Based on end-use, the dialysis market share from the in-center dialysis segment is slated to be worth more than USD 105 billion by 2032. Many advantages of in-center hemodialysis, such as dialysis care by qualified medical professionals, low-risk therapy, and patient evaluation, are contributing to the growing preference for in-center dialysis. Additionally, increasing efforts by healthcare providers to develop new dialysis facilities and integration of innovative technology and solutions to offer better services are projected to support segment revenue.
 

For instance, in March 2022, Texas-based dialysis provider U.S. Renal Care (USRC) extended its in-center hemodialysis services in Southwest Florida with the launch of four new sites.
 

Browse key industry insights spread across 220 pages with 480 market data tables & 15 figures & charts from the report, “Dialysis Market Size By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment {Dialysis Machines, Water Treatment Systems}, Consumables {Dialyzers, Catheters, Access Products, Concentrates}, Services {Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis), Industry Analysis Report, Country Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/dialysis-market
 

Improvement of healthcare infrastructure facilities to promote APAC industry expansion

Asia Pacific dialysis market is projected to record a 6.5% CAGR over between 2023 to 2032. This demand is attributed to the developing healthcare infrastructure in the region, especially in India and China. According to research, the incidences of diabetes are projected to rise by almost 150% in South Asia alone over 2000 - 2035, with China and India having the highest rates.
 

Moreover, the rising number of CKD patients has escalated the necessity of early identification and dialysis treatments. Furthermore, government healthcare institutions are collaborating with private clinics to accommodate more dialysis patients, which is foreseen to boost regional revenue progressthrough 2032.
 

Increasing efforts to receive approvals for innovative product launches to define the industry outlook

AngioDynamics, Inc., U.S. Renal Care, Inc., Rogosin Institute, Dialife SA, Dickinson and Company, Baxter International Inc., Becton, Medtronic Plc., Nikkiso Co. Ltd., Teleflex Incorporated, Toray Industries Inc., Asahi Kasei Corporation, and Satellite Healthcare are some of the leading enterprises operating in the dialysis market.